оттуда
At present, no pharmacological agents with putative neuroprotective actions have demonstrated efficacy in improving outcomes after ischemic stroke, and therefore, other neuroprotective agents are not recommended (Class III; Level of Evidence A). (Revised from the previous guideline)
__________________
Искренне,
Вадим Валерьевич.
|